Lack of p53 immunoreactivity in pancreatic endocrine tumors

By Lee C.  

Pathology, Vol. 28, Iss. 2, 1996-05 ,pp. : 139-141

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Analysis of p53 Tumor Suppressor Gene, H-ras Protooncogene and Proliferating Cell Nuclear Antigen (PCNA) in Squamous Cell Carcinomas of HRA/Skh Mice Following Exposure to 8-Methoxypsoralen (8-MOP) and UVA Radiation (PUVA Therapy)

By Lambertini Luca   Surin Kezia   Ton Thai-Vu   Clayton Natasha   Dunnick June   Kim Yongbaek   Hong Hue-Hua   Devereux Theodora   Sills Robert  

Toxicologic Pathology, Vol. 33, Iss. 2, 2005-01 ,pp. : 292-299

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Proliferating Cell Nuclear Antigen—A Marker for Ovarian Follicle Counts

By Muskhelishvili Levan   Wingard Susan   Latendresse John  

Toxicologic Pathology, Vol. 33, Iss. 3, 2005-01 ,pp. : 365-368

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The Relationship between Proliferating Cell Nuclear Antigen Expression and Histomorphometrical Alterations in Cyclosporin A-Induced Gingival Overgrowth in Rats

By Cetinkaya Burcu   Acikgoz Gokhan   Aydin Oguz   Korkmaz Adnan   Keles Gonca  

Toxicologic Pathology, Vol. 34, Iss. 2, 2006-05 ,pp. : 180-186

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Comparison of silver-staining nucleolar organizer region (AgNOR) counts and proliferating cell nuclear antigen (PCNA) expression in reactive mesothelial hyperplasia and malignant mesothelioma

By Bethwaite Peter   Delahunt Brett   Holloway Linda   Thornton Ann  

Pathology, Vol. 27, Iss. 1, 1995-01 ,pp. : 1-4

Ashgate Publishing Ltd

Access to resources Recommend Favorite